The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
May. 07, 2024
Filed:
Apr. 22, 2022
Applicant:
Resurge Therapeutics, Inc., San Jose, CA (US);
Inventors:
Olof Mikael Trollsas, San Jose, CA (US);
John J. Stankus, Santa Cruz, CA (US);
Shahram Shawn Gholami, Monte Sereno, CA (US);
Assignee:
RESURGE THERAPEUTICS, INC., San Jose, CA (US);
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/337 (2006.01); A61K 9/00 (2006.01); A61K 45/06 (2006.01); A61K 47/34 (2017.01); A61P 13/08 (2006.01); A61P 35/00 (2006.01);
U.S. Cl.
CPC ...
A61K 31/337 (2013.01); A61K 9/0019 (2013.01); A61K 45/06 (2013.01); A61K 47/34 (2013.01); A61P 13/08 (2018.01); A61P 35/00 (2018.01); A61F 2250/0067 (2013.01); A61L 2300/416 (2013.01);
Abstract
Minimally invasive treatment methods for benign prostatic hyperplasia (BPH) tissue. A system includes a sustained release formulation comprising a cytostatic or cytotoxic drug, and an applicator or delivery system for local delivery of a composition comprising or consisting essentially of the sustained release formulation to the prostate. The applicator containing the composition is characterized by a KIR value of between 40 and 400 Centipoise per unit area.